In our series, PAH patients presented a significant rise in CD31+CD42b− but not in CD31+CD42b−CD62E+ EMVs, the latter reflecting EMVs derived from activated endothelial cells. The gene discussed is PECAM1; the disease is pulmonary arterial hypertension.